Clindamycin Phosphate Price Trend, Index and Forecast

Track the latest insights on clindamycin phosphate price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Clindamycin Phosphate Prices Outlook Q3 2025

• USA: USD 160561/MT
• China: USD 140163/MT
• Germany: USD 157767/MT
• India: USD 164804/MT
• Brazil: USD 195200/MT

Clindamycin Phosphate Price Chart

Get real-time access to monthly/quarterly/yearly prices Request Sample

During the third quarter of 2025, the clindamycin phosphate prices in the USA reached 160561 USD/MT in September. Prices increased as demand from pharmaceutical formulation and hospital supply chains remained firm. Producers operated with controlled output amid high regulatory compliance costs, while buyers prioritized supply security for finished dosage manufacturing. Limited availability of alternative suppliers supported procurement at higher negotiated levels. During the third quarter of 2025, the clindamycin phosphate prices in China reached 140163 USD/MT in September. Prices declined due to softer export demand and adequate domestic supply availability. API manufacturers maintained stable production levels, while overseas buyers delayed procurement amid inventory sufficiency. Competitive pricing pressure from regional suppliers influenced trade negotiations. During the third quarter of 2025, the clindamycin phosphate prices in Germany reached 157767 USD/MT in September. Prices moved lower as demand from downstream pharmaceutical processors moderated. Buyers adopted cautious sourcing strategies, focusing on contractual volumes rather than spot purchases. Adequate supply availability and competitive import options shaped procurement behavior across the market. During the third quarter of 2025, the clindamycin phosphate prices in India reached 164804 USD/MT in September. Prices increased supported by strong demand from export-oriented pharmaceutical manufacturers. API producers benefited from steady international orders, while controlled production schedules and compliance-related costs influenced supply availability. Buyers emphasized long-term sourcing arrangements to ensure continuity. During the third quarter of 2025, the clindamycin phosphate prices in Brazil reached 195200 USD/MT in September. Prices rose due to sustained demand from domestic pharmaceutical formulation units and reliance on imports. Supply chain lead times and regulatory requirements influenced procurement planning, while buyers focused on securing consistent volumes for essential medicine production.

Clindamycin Phosphate Prices Outlook Q2 2025

• USA: USD 156340/MT
• China: USD 143170/MT
• Germany: USD 162982/MT
• India: USD 159078/MT
• Brazil: USD 187152/MT

During the second quarter of 2025, the clindamycin phosphate prices in the USA reached 156340 USD/MT in June. Market activity was shaped by consistent demand from pharmaceutical formulation units and hospital supply chains. Buyers focused on structured procurement aligned with production schedules, while producers maintained output discipline to meet regulatory and quality requirements. Inventory planning and supplier qualification remained central considerations for formulators. During the second quarter of 2025, the clindamycin phosphate prices in China reached 143170 USD/MT in June. Demand from export-oriented pharmaceutical manufacturers followed routine ordering cycles. Producers operated with adequate capacity, while buyers emphasized documentation, compliance standards, and shipment reliability. Procurement decisions were influenced by regulatory approvals and alignment with international customer requirements. During the second quarter of 2025, the clindamycin phosphate prices in Germany reached 162982 USD/MT in June. Pharmaceutical processors sourced material based on validated supplier relationships and quality certifications. Buyers prioritized consistency and traceability, while suppliers ensured uninterrupted availability to support regulated manufacturing operations. Demand followed planned formulation schedules rather than spot-market activity. During the second quarter of 2025, the clindamycin phosphate prices in India reached 159078 USD/MT in June. API manufacturers focused on meeting export commitments and maintaining compliance with regulated market standards. Buyers engaged in scheduled procurement tied to shipment planning, while producers managed capacity utilization to support steady international supply obligations. During the second quarter of 2025, the clindamycin phosphate prices in Brazil reached 187152 USD/MT in June. Market conditions reflected import-dependent sourcing and procurement by domestic pharmaceutical formulators. Buyers emphasized supply continuity, regulatory documentation, and lead-time management, while distributors coordinated logistics to meet production timelines for finished dosage manufacturing.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the clindamycin phosphate prices.

Europe Clindamycin Phosphate Price Trend

Q3 2025:

As per the clindamycin phosphate price index, Europe recorded lower prices, driven by declines in Germany alongside broader softening across regional pharmaceutical procurement channels. Demand from formulation units eased as production schedules normalized, leading buyers to rely more heavily on contractual volumes. Regulatory compliance, audit readiness, and supplier qualification remained central to sourcing decisions. Producers focused on maintaining validated supply chains, while import availability and documentation requirements influenced cross-border procurement across the region.

Q2 2025:

Europe’s market conditions were shaped by procurement behavior across multiple regulated pharmaceutical markets. Demand from formulation units followed planned manufacturing cycles, with buyers emphasizing supplier consistency, pharmacopoeia compliance, and traceability. Producers ensured uninterrupted availability to meet regulatory obligations, while sourcing strategies reflected coordination between domestic production and approved import channels rather than shifts in consumption intensity. This analysis can be extended to include detailed clindamycin phosphate price information for a comprehensive list of countries.

Region	Countries Covered
Europe	Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.

North America Clindamycin Phosphate Price Trend

Q3 2025:

As per the clindamycin phosphate price index, North America posted higher prices, led by increases in the USA. Demand from branded and generic drug manufacturers remained firm, particularly for hospital-administered antibiotics. Buyers prioritized supply security and regulatory alignment, while producers managed output within stringent quality frameworks. Procurement strategies emphasized long-term agreements and validated supplier relationships to ensure continuity for essential formulations.

Q2 2025:

North America’s market environment reflected structured procurement activity across pharmaceutical manufacturers. Buyers focused on inventory planning, regulatory documentation, and compliance with Good Manufacturing Practice standards. Producers aligned output with confirmed formulation requirements, while distributors coordinated logistics to support uninterrupted supply to downstream drug manufacturing facilities. Specific clindamycin phosphate historical data within the United States and Canada can also be provided.

Region	Countries Covered
North America	United States and Canada

Middle East and Africa Clindamycin Phosphate Price Trend

Q3 2025:

As per clindamycin phosphate price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.

Q2 2025:

The report explores the clindamycin phosphate pricing trends and clindamycin phosphate price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices. In addition to region-wise data, information on clindamycin phosphate prices for countries can also be provided.

Region	Countries Covered
Middle East & Africa	Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.

Asia Pacific Clindamycin Phosphate Price Trend

Q3 2025:

In the Asia Pacific region, clindamycin phosphate prices showed mixed movement, with increases in India and declines in China. In India, export-oriented demand from regulated markets supported procurement interest, while producers operated within controlled capacity frameworks. In China, softer overseas demand and sufficient domestic availability influenced buyer behavior. Across the region, regulatory approvals, audit schedules, and documentation requirements played a critical role in shaping trade flows.

Q2 2025:

Clindamycin phosphate market dynamics were defined by export-driven production and structured sourcing across major manufacturing hubs. Buyers aligned procurement with shipment schedules and regulatory clearances, while producers focused on maintaining compliance with international quality standards. Supply planning emphasized audit readiness, documentation accuracy, and coordination with global pharmaceutical customers rather than volume-driven purchasing. This clindamycin phosphate price analysis can be expanded to include a comprehensive list of countries within the region.

Region	Countries Covered
Asia Pacific	China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Latin America Clindamycin Phosphate Price Trend

Q3 2025:

In Latin America, clindamycin phosphate prices increased, led by higher prices in Brazil. Demand from domestic pharmaceutical formulation units remained consistent, supported by reliance on imports. Buyers emphasized supplier reliability, regulatory compliance, and lead-time management. Distributors coordinated logistics and documentation to ensure uninterrupted supply for essential medicine production.

Q2 2025:

Market conditions were shaped by import-dependent sourcing and routine procurement by pharmaceutical manufacturers across the region. Buyers focused on continuity of supply, regulatory approvals, and alignment with formulation schedules. Inventory planning reflected lead times and storage requirements, while distributors managed logistics to meet consistent downstream manufacturing needs. This comprehensive review can be extended to include specific countries within the region.

Region	Countries Covered
Latin America	Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.

Clindamycin Phosphate Pricing Report, Market Analysis, and News

IMARC's latest publication, “Clindamycin Phosphate Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents꧃ a detailed examination of the clindamycin phosphate market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of clindamycin phosphate at major🧸 ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed clindamycin phosphate prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting clindamycin phosphate pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Clindamycin Phosphate Industry Analysis

The global clindamycin phosphate industry size reached USD 872.6 Million in 2025. By 2034, IMARC Group expects the market to reach USD 1,352.0 Million, at a projected CAGR of 4.98% during 2026-2034. Market growth is supported by rising demand for antibiotic therapies, expanding pharmaceutical manufacturing cap﷽acity, and sustained consumption driven by hospital use and treatment of bacterial infections across both developed and emerging healthcare markets.

Latest News and Developments:

• February 2025: Glenmark Pharmaceuticals Inc., USA announced the commercial launch of Clindamycin Phosphate Foam, 1% for the treatment of acne, marking a strategic expansion of its dermatology product portfolio in the U.S. generics market. The newly launched foam product is bioequivalent and therapeutically equivalent to the reference listed drug Evoclin Foam, 1% previously marketed by Mylan Pharmaceuticals Inc., and aims to provide dermatologists and patients with an effective antibiotic foam option for acne management.

Product Description

Clindamycin phosphate is a semi-synthetic antibiotic from the lincosamide class, derived from lincomycin. It is frequently used to treat a range of bacterial infections, both topically and systemically. Clindamycin phosphate is available in multiple formulations, including oral capsules, intravenous injections, and topical gels, making it versatile in treating different types of infections. The primary applications of clindamycin phosphate span across multiple medical fields due to its broad-spectrum antibacterial properties. It is particularly effective against anaerobic bacteria and certain protozoa, making it a valuable tool in treating infections that other antibiotics might not effectively address. In dermatology, it is widely used in topical formulations to treat acne vulgaris by reducing the population of Propionibacterium acnes on the skin and decreasing inflammation. Another significant use is in the management of bone and joint infections, such as osteomyelitis. Clindamycin phosphate is a crucial drug in orthopedic treatments because of its capacity to permeate bone tissue, which allows it to reach the infection site and exert its antibacterial effects.

Report Coverage

Key Attributes	Details
Product Name	Clindamycin Phosphate
Report Features	Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Clindamycin Phosphate Price Analysis, and Segment-Wise Assessment.
Currency/Units	US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered	The current coverage includes analysis at the global and regional levels only.    Based on your requirements, we can also customize the report and provide specific information for the following countries:    Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*   Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*    North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers	Company Overview Business Description Recent Trends and Developments
Customization Scope	The report can be customized as per the requirements of the customer
Report Price and Purchase Option	Plan A: Monthly Updates - Annual Subscription Scope Historical Data for the Current Month Forecast for Next Month Total Deliverables Per Year: 12 (One Per Month) Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year Plan B: Quarterly Updates - Annual Subscription Scope Historical Data for the Current Quarter Forecast for Next Quarter Total Deliverables Per Year: 4 (One Per Quarter) Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year Plan C: Biannually Updates - Annual Subscription Scope Historical Data for the Current Half Forecast for the Next Half Total Deliverables Per Year: 2 (One Per 6 Months) Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support	360-degree analyst support after report delivery
Delivery Format	PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of clindamycin phosphate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting clindamycin phosphate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The clindamycin phosphate price charts ensure our clients remain at the forefront of the industry.